New Delhi [India], January 11 (ANI): Senior shooter Tejaswini Sawant out-staged Punjab's Anjum Moudgil, in a battle of two Olympic quota holders, to win the Women's 50M Rifle 3 positions T1 trials, at the Dr. Karni Singh Shooting range on Monday.
Jaipur (Rajasthan) [India], January 11 (ANI): Ahead of the COVID-19 vaccine rollout in the country, Rajasthan Health Minister Dr Raghu Sharma hit out at those questioning the efficacy of vaccines, stating that trials have been conducted and there is no time to raise apprehensions over inocul
Bhopal (Madhya Pradesh) [India], January 9 (ANI): After a man died days after participating in the vaccine trial in Bhopal, Madhya Pradesh Chief Minister Shivraj Singh Chauhan on Saturday urged the public to refrain from spreading "misconception" on the effects of vaccination and treat the "
Raipur (Chhattisgarh) [India], January 9 (ANI): Chhattisgarh Health Minister TS Singh Deo on Saturday said that COVID-19 vaccination should not be started before the results of Hyderabad-based drug firm Bharat Biotech's coronavirus vaccine--Covaxin--are clearly out.
New Delhi [India], January 9 (ANI): Reigning world number one Elavenil Valarivan and Assam's Hriday Hazarika on Saturday won the women's and men's 10m Air Rifle T1 national selection trials respectively at the Dr. Karni Singh Shooting range.
New Delhi [India], January 8 (ANI): After taking the first shot of Covaxin, Ecuador's Envoy to India Hector Cueva Jacome on Friday said that Bharat Biotech and Serum Institute are good companies, adding that he talked to researchers in US and Ecuador and then took part in the trials.
New Delhi [India], January 8 (ANI): The Bharat Biotech International Limited has sent a proposal to the Drugs Controller General of India (DCGI) for conducting the phase 1 trials of a nasal vaccine against COVID-19, informed a government official on Friday.
New Delhi [India], January 7 (ANI): Senior Men's 3-Positions (3P) rifle shooter and double Olympian Sanjeev Rajput showed good form by shooting competitively for the first time since the coronavirus induced lockdown, to win the 50m Rifle 3P T1 trials at the Dr Karni Singh Shooting range.
Hyderabad (Telangana) [India], January 7 (ANI): The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials of its indigenously manufactured COVID-19 vaccine 'Covaxin.'
New Delhi [India], January 5 (ANI): The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and immunogenicity clinical trial data while phase thre
New Delhi [India], January 4 (ANI): Coming down heavily on critics expressing doubts about the Bharat Biotech's indigenously developed coronavirus vaccine COVAXIN, the Hyderabad-based biotech major's managing director Dr Krishna Ella on Monday slammed the critics for targeting Indian clinica
Hyderabad (Telangana) [India], January 4 (ANI): Covaxin, the indigenous vaccine developed by Bharat Biotech against COVID-19 in collaboration with ICMR, is 200 per cent safe, company's Chairman and Managing Director Dr Krishna Ella has said and noted that it has shown less than 10 per cen